Halozyme Therapeutics (HALO) Peer Comparison

$100.27

up-down-arrow $-0.40 (-0.40%)

As on 13-Nov-2026 16:02EST

Market cap

info icon

$11,432 Mln

Revenue (TTM)

info icon

$1,802 Mln

P/E Ratio

info icon

25.2

P/B Ratio

info icon

97.2

Div. Yield

info icon

0 %

Edit peer-selector-edit
Halozyme Therapeutics (HALO) Exelixis (EXEL) Ascendis Pharma A/S - ADR Kymera Therapeutics (KYMR) Madrigal Pharmaceuticals (MDGL)
Market cap ($ Mln)
11,432 16,837 18,064 10,891 9,928
Revenue ($ Mln)
1,802 2,497 1,208 102 1,428
Net Profit ($ Mln)
485.42 885.14 890.37 -349.47 -155.46
Net Margin (%)
26.93 35.45 73.69 -341.87 -10.89
RoE (%)
-- 46.96 88.40 -22.16 -26.57
Price to Earnings
25.19 20.66 18.11 -- --
Price-To-Book
97.15 9.18 10.44 6.72 15.76

Income Statement ($ Mln)

Liabilities ($ Mln)

Assets ($ Mln)

Cashflow ($ Mln)

Ratios

Profitability Ratios

Growth Ratios

Valuation Ratios

Solvency Ratios

Operating Efficiency Ratios

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...

Informed fund ideas, better judgment. Every month. Mutual Fund Insight, every month since October 2002.

Take charge. Know more. Keep more. Mutual Fund Insight helps you do all three — every month